Quantcast

Posts related to ‘Medical’

J&J… When Beating Earnings Hits A Headwind (JNJ)

Johnson & Johnson (NYSE: JNJ) managed to marginally beat earnings expectations this Tuesday morning.  This is the first of the consumer products and medical products companies to report, so this ...
Read Full Story »

The $1,000 Genome Finally Arrives (LIFE)

Personalized medicine is coming... if you can afford it.  The quest for the $1,000 genomic map has been a race and it appears to be closer and closer.  News is out ...
Read Full Story »

It Takes a Recession to Slow U.S. Health Care Cost Increases

It takes a recession to slow what has normally been runaway U.S. health care costs. The trend may be part of a road map to keep costs down. These costs have risen ...
Read Full Story »

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

The biotech sector has seen its share of ups and downs in 2011 and prior years.  It is almost always the case that some of the top performing stocks each ...
Read Full Story »

Top Med-Tech Stock Picks for 2012 (BSX, ISRG, STJ)

Many research firms have been coming up with their best ideas lists for 2012.  Today brought a list of top picks in the medical technology and medical devices sector from ...
Read Full Story »

Get Ready for a Pfizer Dividend Hike… A Holiday Gift From Big Pharma (PFE, MRK, WPI, TEVA)

We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks and months ahead.  Among those we expect to raise the ...
Read Full Story »

Dendreon Raising $125 Million Via I.P. Sale (DNDN, MRK)

Dendreon Corporation (NASDAQ: DNDN) is supposed to be the king of prostate cancer with its PROVENGE treatment.  Unfortunately, PROVENGE sales ran slower than expected after the FDA took forever to ...
Read Full Story »

Sequenom Files To Raise Capital (SQNM)

Sequenom, Inc. (NASDAQ: SQNM) has just filed to raise up to $150 million in a mixed securities shelf offering.  The diagnostics company could sell any combination of Common Stock, Preferred ...
Read Full Story »

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1 billion to fail to get the drug to market. Like ...
Read Full Story »

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public.  So what about when a company decides to unlock shareholder value by ...
Read Full Story »

Boston Scientific Gets New Boss, Eventually (BSX, JNJ, ABT)

Medical device maker Boston Scientific Corp. (NYSE: BSX) has named a new president who will take over on October 17th and who will then be elevated to CEO on November ...
Read Full Story »

Census Data: Poverty Rates, Median Income Drops Get Worse & Worse

The Census Bureau is out with the 2010 figures on income, poverty, and health insurance.  About all you can hope for is that 2011 is magically better than 2010 ...
Read Full Story »

The Eleven Most Implanted Medical Devices In America

Implanted medical devices are one of the most profitable businesses of the U.S. healthcare industry. While many devices help extend and improve quality of life, a great many others may ...
Read Full Story »

The States That Spend The Most (And Least) On Healthcare For The Poor

The federal and state governments spend approximately $5,296 a year on medical treatment for each poor and disabled person on Medicaid. Over 58 million Americans are enrolled in Medicaid. These ...
Read Full Story »

Where Americans Live the Longest, and Why

Despite being one of the wealthiest countries in the world, the United States ranks 37th in life expectancy, according to the World Health Organization’s most recent longevity report. While the ...
Read Full Story »